Offer - Urjas Oil for just ₹ 1 X
Ipravent 500 Mcg Respule is a commercial drug that is prescribed in the form of Respules. It is primarily used for the treatment of COPD, Asthma. Secondary and off-label uses of Ipravent 500 Mcg Respule have also been mentioned below.
The right dosage of Ipravent 500 Mcg Respule depends on the age, gender, and medical history of the patient. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Refer to the dosage section for a detailed discussion.
Besides the aforementioned side effects, there are other adverse effects of Ipravent 500 Mcg Respule as well, which are listed below. Such side effects of Ipravent 500 Mcg Respule normally do not last long and go away once the treatment is completed. However, if these continue for a longer time, consult your doctor right away.
Furthermore, you should know that effect of Ipravent 500 Mcg Respule is Moderate for pregnant women and Moderate for women who are breastfeeding. Further, the section on Ipravent 500 Mcg Respule related warnings talks about Ipravent 500 Mcg Respule's effects on the liver, heart and kidney.
Other conditions have been mentioned below in the Ipravent 500 Mcg Respule contraindications section.
Besides this, Ipravent 500 Mcg Respule may also have severe interaction with some medicines. See below for a complete list.
In addition to these precautions, you may also note that Ipravent 500 Mcg Respule is not safe while driving, and is is not addictive in nature.
Ipravent 500 Mcg Respule is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Is the use of Ipravent 500 Mcg Respule safe for pregnant women?
Ipravent may cause moderate side effects during pregnancy. If you feel its harmful effects, then stop taking this drug immediately, and do not take Ipravent again without your doctor's advice.
Is the use of Ipravent 500 Mcg Respule safe during breastfeeding?
Ipravent may lead to some side effects in breastfeeding women. If you witness any unusal symptoms after taking Ipravent, discontinue its use and call your doctor right away. Follow your doctor's advice regarding the use of Ipravent.
What is the effect of Ipravent 500 Mcg Respule on the Kidneys?
Ipravent may have mild side effects on the kidneys.
What is the effect of Ipravent 500 Mcg Respule on the Liver?
Ipravent is rarely harmful for the liver.
What is the effect of Ipravent 500 Mcg Respule on the Heart?
Ipravent can have moderate side effects on the heart. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
If you are suffering from any of the following diseases, you should not take Ipravent 500 Mcg Respule unless your doctor advises you to do so -
Is this Ipravent 500 Mcg Respule habit forming or addictive?
Forming a habit of Ipravent 500 Mcg Respule has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
After taking Ipravent 500 Mcg Respule you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Ipravent 500 Mcg Respule should be used only after doctor's advice.
Is it able to treat mental disorders?
No, the use of Ipravent 500 Mcg Respule in mental disorders is not effective.
Interaction between Food and Ipravent 500 Mcg Respule
There isn't any research available on the side effects of taking Ipravent 500 Mcg Respule with food.
Interaction between Alcohol and Ipravent 500 Mcg Respule
No research has been done on this till date. Therefore, it is not known what the effect of taking Ipravent 500 Mcg Respule with alcohol will be.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 705
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 116
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Atrovent® HFA (ipratropium bromide HFA)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Ipravent® (ipratropium bromide)